Fallica et al. recently designed, synthesized, and tested a new battery of acetamide-based HO-1 inhibitors endowed with strong antiproliferative activity against a panel of tumoral cells, including lung, prostate, and GBM cells [44]. Here, HMOX1 is linked to glioblastoma.